Trump administration’s embattled FDA vaccine chief is leaving for the second time

Trump's divisive FDA vaccine regulator self-destructs, will exit agency (again)

It's unclear what Prasad's FDA exit means, but some drug makers are happy to see him go.

FDA Vaccine and Biotech Chief Dr. Vinay Prasad LEAVES Agency for SECOND Time in Under a Year | The Gateway Pundit | by Jim Hᴏft

The Food and Drug Administration (FDA) has confirmed that Dr.

UniQure leads genetic medicine biotech rally after news of Prasad’s exit

Prasad contributed to an uncertain regulatory climate for gene therapy makers focused on rare conditions. Shares of many developers rose on the chance of a more industry-friendly successor.

CBER chief Vinay Prasad to leave FDA once again

For the second time in less than a year, Vinay Prasad has departed from the FDA, after a string of controversial regulatory decisions

Trump administration’s embattled FDA vaccine chief is leaving for the second time

WASHINGTON — The Food and Drug Administration’s embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he’s departed after controversial decisions involving the review of vaccinations and specialty drugs for rare diseases. Read more...

5 lessons from Vinay Prasad's turbulent tenure at the FDA

Food and Drug Administration official Vinay Prasad self-destructed last week. The FDA announced Friday evening that he would step down next month after a series of controversial decisions about vaccines and gene therapies. His unique ability to attract criticism — even when his bosses, including the president, wanted him to keep his head low — did him in.  Prasad’s defenders will present his arc as that of a heroic figure falling because he stoo…